{"id":"F2007L02636","name":"National Health Act 1953 - Determination under subsection 85AB(1) (No. PB 66 of 2007)","slug":"national-health-act-1953-determination-under-subsection-85ab-1-no-pb-66-of-2007","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":68465,"registerId":"commonwealth-F2007L02636-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Determination under subsection 85AB(1) (No. PB 66 of 2007)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n![](image.001.png)\n\n \n\nCOMMONWEALTH OF AUSTRALIA\n\nInstrument number PB 66 of 2007\n\nDetermination under subsection 85AB(1) of the National Health Act 1953\n\nI, STEPHEN DELLAR, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, make this instrument under subsection 85AB(1) of the National Health Act 1953.\n\nDated 14 August 2007\n\n \n\n \n\n \n\nSTEPHEN DELLAR\n\nAssistant Secretary\n\nPharmaceutical Evaluation Branch\n\nDepartment of Health and Ageing\n\n \n\n \n\nDetermination – drugs on F1 \n\n \n\n1 Commencement\n\n This instrument commences on 1 September 2007.\n\n \n\n2 Drugs on F1\n\nThe listed drug “Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids” is on F1.\n\n The listed drug “Cetuximab” is on F1.\n","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2399},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"The instrument performs exactly the specific task authorised by subsection 85AB(1) of the National Health Act 1953: determining which listed drugs are on F1. It has not expanded beyond this original purpose."},"complexity_factors":["Only two operative provisions (commencement and listing)","No definitions or interpretation section","No cross-references to other sections within the instrument","No conditional logic, exceptions, or procedural requirements"],"plain_english_summary":"This determination adds two medicines—an amino‑acid synthetic infant formula supplemented with long‑chain polyunsaturated fatty acids and the biologic cetuximab—to F1 of the PBS, so pharmacists must dispense the exact brand the prescriber specifies. \n\nThat preserves brand‑specific efficacy and safety for a specialised nutritional product and a biological cancer therapy, but prevents switching to potentially cheaper generic or alternate brands."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-determination-under-subsection-85ab-1-no-pb-66-of-2007","history":"/api/acts/national-health-act-1953-determination-under-subsection-85ab-1-no-pb-66-of-2007/history","analysis":"/api/acts/national-health-act-1953-determination-under-subsection-85ab-1-no-pb-66-of-2007/analysis","conflicts":"/api/acts/national-health-act-1953-determination-under-subsection-85ab-1-no-pb-66-of-2007/conflicts","importantCases":"/api/acts/national-health-act-1953-determination-under-subsection-85ab-1-no-pb-66-of-2007/important-cases","documents":"/api/acts/national-health-act-1953-determination-under-subsection-85ab-1-no-pb-66-of-2007/documents"}}